JPWO2021070696A1 - - Google Patents
Info
- Publication number
- JPWO2021070696A1 JPWO2021070696A1 JP2021551358A JP2021551358A JPWO2021070696A1 JP WO2021070696 A1 JPWO2021070696 A1 JP WO2021070696A1 JP 2021551358 A JP2021551358 A JP 2021551358A JP 2021551358 A JP2021551358 A JP 2021551358A JP WO2021070696 A1 JPWO2021070696 A1 JP WO2021070696A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019185266 | 2019-10-08 | ||
| JP2019185266 | 2019-10-08 | ||
| PCT/JP2020/037100 WO2021070696A1 (ja) | 2019-10-08 | 2020-09-30 | Ｃｔｌａ－４阻害活性を有する環状ペプチド、及びその用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2021070696A1 true JPWO2021070696A1 (https=) | 2021-04-15 |
| JPWO2021070696A5 JPWO2021070696A5 (https=) | 2022-06-21 |
| JP7477182B2 JP7477182B2 (ja) | 2024-05-01 |
Family
ID=75437884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021551358A Active JP7477182B2 (ja) | 2019-10-08 | 2020-09-30 | Ｃｔｌａ－４阻害活性を有する環状ペプチド、及びその用途 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US12565517B2 (https=) |
| EP (1) | EP4043076B1 (https=) |
| JP (1) | JP7477182B2 (https=) |
| WO (1) | WO2021070696A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250154200A1 (en) * | 2021-12-20 | 2025-05-15 | Kansas State University Research Foundation | Cyclic peptide for cancer immunotherapy |
| CN115636872B (zh) * | 2022-06-24 | 2026-02-24 | 中国农业科学院生物技术研究所 | 木糖酸肽类化合物及其在抗寄生虫药物中的应用 |
| CN116178490A (zh) * | 2022-07-08 | 2023-05-30 | 北京工商大学 | 一种高活性淀粉酶抑制活性肽及其制备方法和应用 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009060905A (ja) * | 1993-07-26 | 2009-03-26 | Dana-Farber Cancer Inst Inc | Ｂ７−２：ｃｔｌａ４／ｃｄ２８カウンターレセプター |
| US20140051645A1 (en) * | 2010-12-02 | 2014-02-20 | Pieris Ag | Muteins of human lipocalin 2 with affinity for ctla-4 |
| JP2016526885A (ja) * | 2013-06-27 | 2016-09-08 | アリゲーター バイオサイエンス アーベー | Ｃｔｌａ−４に対する親和性が改善したｃｄ８６バリアント |
| WO2017213158A1 (ja) * | 2016-06-07 | 2017-12-14 | 株式会社カネカ | リボソームディスプレイ複合体およびその製造方法 |
| JP2018519255A (ja) * | 2015-05-01 | 2018-07-19 | ベイラー カレッジ オブ メディスンＢａｙｌｏｒ Ｃｏｌｌｅｇｅ Ｏｆ Ｍｅｄｉｃｉｎｅ | Ｃｔｌａ−４アンタゴニストによる、免疫応答の増強方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6084067A (en) | 1993-07-26 | 2000-07-04 | Dana-Farber Cancer Institute | CTLA4/CD28 ligands and uses therefor |
| JP5605602B2 (ja) | 2007-03-26 | 2014-10-15 | 国立大学法人 東京大学 | 環状ペプチド化合物の合成方法 |
| JP4931135B2 (ja) | 2007-05-02 | 2012-05-16 | 国立大学法人 東京大学 | リボソームディスプレイ |
| EP2647721B1 (en) | 2010-12-03 | 2019-02-27 | The University of Tokyo | Peptide with safer secondary structure, peptide library, and production methods for same |
| JP5948673B2 (ja) | 2011-03-10 | 2016-07-06 | ジーンフロンティア株式会社 | リポ多糖混入量を低減した蛋白質合成用組成物、該組成物を用いた蛋白質製造方法 |
| JP6322411B2 (ja) | 2011-09-30 | 2018-05-09 | 中外製薬株式会社 | 複数の生理活性を有する抗原の消失を促進する抗原結合分子 |
| TW202446781A (zh) | 2011-12-28 | 2024-12-01 | 日商中外製藥股份有限公司 | 胜肽化合物之製造方法 |
| WO2017217545A1 (ja) | 2016-06-16 | 2017-12-21 | 国立大学法人東京大学 | プレキシンの結合調節剤 |
| JP7134677B2 (ja) | 2018-04-05 | 2022-09-12 | 日本信号株式会社 | 駐車位置記憶システム |
-
2020
- 2020-09-30 US US17/767,550 patent/US12565517B2/en active Active
- 2020-09-30 JP JP2021551358A patent/JP7477182B2/ja active Active
- 2020-09-30 EP EP20874686.7A patent/EP4043076B1/en active Active
- 2020-09-30 WO PCT/JP2020/037100 patent/WO2021070696A1/ja not_active Ceased
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009060905A (ja) * | 1993-07-26 | 2009-03-26 | Dana-Farber Cancer Inst Inc | Ｂ７−２：ｃｔｌａ４／ｃｄ２８カウンターレセプター |
| US20140051645A1 (en) * | 2010-12-02 | 2014-02-20 | Pieris Ag | Muteins of human lipocalin 2 with affinity for ctla-4 |
| JP2016526885A (ja) * | 2013-06-27 | 2016-09-08 | アリゲーター バイオサイエンス アーベー | Ｃｔｌａ−４に対する親和性が改善したｃｄ８６バリアント |
| JP2018519255A (ja) * | 2015-05-01 | 2018-07-19 | ベイラー カレッジ オブ メディスンＢａｙｌｏｒ Ｃｏｌｌｅｇｅ Ｏｆ Ｍｅｄｉｃｉｎｅ | Ｃｔｌａ−４アンタゴニストによる、免疫応答の増強方法 |
| WO2017213158A1 (ja) * | 2016-06-07 | 2017-12-14 | 株式会社カネカ | リボソームディスプレイ複合体およびその製造方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021070696A1 (ja) | 2021-04-15 |
| EP4043076C0 (en) | 2024-06-26 |
| US12565517B2 (en) | 2026-03-03 |
| EP4043076A4 (en) | 2024-01-03 |
| JP7477182B2 (ja) | 2024-05-01 |
| US20240092836A1 (en) | 2024-03-21 |
| EP4043076A1 (en) | 2022-08-17 |
| EP4043076B1 (en) | 2024-06-26 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220407 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220407 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220614 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221212 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230328 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230719 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230905 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20231128 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240131 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240201 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20240220 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240409 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240411 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7477182 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |